Hippocampus and basal forebrain volumes modulate effects ofanticholinergic treatment on delayed recall in healthy older adults

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

Volumn 1, Issue 2, 2015, Pages 216-219

  Teipel, Stefan J ^a,b   Bruno, Davide ^c   Grothe, Michel J ^a   Nierenberg, Jay ^d,e   Pomara, Nunzio ^d,e  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c LIVERPOOL HOPE UNIVERSITY   (United Kingdom)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Cholinergic system; Episodic memory; Hippocampus; Human brain; Muscarinic receptor antagonist

Indexed keywords

EID: 84938691533     PISSN: None     EISSN: 23528729     Source Type: Journal    
DOI: 10.1016/j.dadm.2015.01.007     Document Type: Article

References (19)

1. Guthrie S.K., Manzey L., Scott D., Giordani B., Tandon R. Comparison of central and peripheral pharmacologic effects of biperiden and trihexyphenidyl in human volunteers. J Clin Psychopharmacol 2000, 20:77-83.
2. Nakra B.R., Margolis R.B., Gfeller J.D., Grossberg G.T., Sata L.S. The effect of a single low dose of trihexyphenidyl on memory functioning in the healthy elderly. Int Psychogeriatr 1992, 4:207-214.
3. Pomara N., Yi L., Belzer K., Facelle T.M., Willoughby L.M., Sidtis J.J. Retrograde facilitation of verbal memory by trihexyphenidyl in healthy elderly with and without the APOE epsilon4 allele. Eur Neuropsychopharmacol 2010, 20:467-472.
4. Dumas J.A., Newhouse P.A. The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation. Pharmacol Biochem Behav 2011, 99:254-261.
5. Mesulam M.M. The cholinergic innervation of the human cerebral cortex. Prog Brain Res 2004, 145:67-78.
6. Opitz B. Memory function and the hippocampus. Front Neurol Neurosci 2014, 34:51-59.
7. Mesulam M.M., Geula C. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J Comp Neurol 1988, 275:216-240.
8. Mesulam M.M., Volicer L., Marquis J.K., Mufson E.J., Green R.C. Systematic regional differences in the cholinergic innervation of the primate cerebral cortex: distribution of enzyme activities and some behavioral implications. Ann Neurol 1986, 19:144-151.
9. Pomara N., Willoughby L.M., Wesnes K., Sidtis J.J. Increased anticholinergic challenge-induced memory impairment associated with the APOE-epsilon4 allele in the elderly: a controlled pilot study. Neuropsychopharmacology 2004, 29:403-409.
10. Buschke H. Selective reminding for analysis of memory and learning. J Verb Learn Verb Behav 1973, 12:543-550.
11. Grothe M.J., Schuster C., Bauer F., Heinsen H., Prudlo J., Teipel S.J. Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia. J Neurol 2014, 261:1939-1948.
12. Kilimann I., Grothe M., Heinsen H., Alho E.J., Grinberg L., Amaro E., et al. Subregional basal forebrain atrophy in Alzheimer's disease: a multicenter study. J Alzheimers Dis 2014, 40:687-700.
13. Sakamoto Y., Ishiguro M., Kitagawa G. Akaike information criterion statistics 1986, D. Reidel Publishing Company, Boston.
14. Burke R.E., Fahn S. Pharmacokinetics of trihexyphenidyl after short-term and long-term administration to dystonic patients. Ann Neurol 1985, 18:35-40.
15. Fox J. Effect displays in R for generalised linear models. J Stat Softw 2003, 8:1-27.
16. Kenward M.G., Jones B. Design and analysis of cross-over trials. Epidemiology and medical statistics 2008, 464-490. Elsevier, New York. C.R. Rao, J.P. Miller, D.C. Rao (Eds.).
17. Muir J.L. Acetylcholine, aging, and Alzheimer's disease. Pharmacol Biochem Behav 1997, 56:687-696.
18. Pomara N., Nolan K., Halpern G. Scopolamine-induced impairment as a potential predictor of Alzheimer's disease in individuals with apolipoprotein E type 4 alleles. Neurochem Res 1995, 20:1519-1520.
19. Snyder P.J., Lim Y.Y., Schindler R., Ott B.R., Salloway S., Daiello L., et al. Microdosing of scopolamine as a "cognitive stress test": rationale and test of a very low dose in an at-risk cohort of older adults. Alzheimers Dement 2014, 10:262-267.